; (ii) representatives from nonprofit organizations with expertise related to the health of women and children; (iii) relevant industry representatives; (iv) individuals with ethical and legal expertise in clinical trials and research; (v) representatives from relevant nonprofit organizations with expertise in clinical research; and (vi) other representatives, as the Secretary determines appropriate. (B) Limitations The non-Federal members of the Committee shall compose not more than one-half, and not less than one-third, of the total membership of the Committee. (C) Appointment The Secretary shall appoint the non-Federal members of the Committee. (D) Terms The non-Federal members of the Committee shall serve for a term of 4 years, and may be reappointed for 1 additional 4-year term. Any non-Federal member appointed to fill a vacancy for an unexpired term shall be appointed for the remainder of such term. A non-Federal member may serve after the expiration of the member’s term until a successor has taken office. (d) Administrative support The Secretary shall provide the Committee such administrative support as the Secretary determines to be necessary for carrying out this section. (e) Meetings The Committee shall meet at least 2 times each year and shall convene public meetings, as appropriate, to fulfill its duties under subsection (b). (f) Report to Congress (1) In general Not later than 1 year after the date of enactment of this Act, and every other year thereafter, the Committee shall prepare and submit to the Secretary, the Committee on Health, Education, Labor, and Pensions of the Senate, and the Committee on Energy and Commerce of the House of Representatives a report on— (A) the progress of Federal agencies in implementing the recommendations and implementation plan described in subsection (b)(3); (B) Federal activities undertaken to advance the inclusion of pregnant and lactating women in clinical research